Journal
ONCOTARGET
Volume 8, Issue 31, Pages 50325-50326Publisher
IMPACT JOURNALS LLC
DOI: 10.18632/oncotarget.17960
Keywords
Kaposi sarcoma; lenalidomide; pomalidomide; MHC-I; immunomodulatory drugs; KSHV